Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Download PDF
Thromb Haemost 2005; 94(04): 895-896
DOI: 10.1055/s-0037-1615587
DOI: 10.1055/s-0037-1615587
Letters to the Editor
Hypersensitivity to the pentasaccharide fondaparinux in patients with delayed-type heparin allergy
Authors
Further Information
Publication History
Received09 May 2005
Accepted after resubmission01 August 2005
Publication Date:
11 December 2017 (online)
-
References
- 1 Estrada Rodriguez JL, Gozalo Reques F, Ortiz de Urbina J. et al. Generalized eczema induced by nadroparin. J Investig Allergol Clin Immunol 2003; 13: 6970.
- 2 Bussey H, Francis JL. Heparin Consensus Group. Heparin overview and issues. Pharmacotherapy 2004; 24: 103S-107S.
- 3 Parody R, Oliver A, Souto JC. et al. Fondaparinux (Arixtra) as an alternative anti-thrombotic prophylaxis when there is hypersensitivity to low molecular weight and unfractionated heparins. Haematologica 2003; 88: ECR32.
- 4 Sacher C, Hunzelmann N. Tolerance to the synthetic pentasaccharide fondaparinux in heparin sensitization. Allergy 2003; 58: 1318-9.
- 5 Ludwig RJ, Beier C, Lindhoff-Last E. et al. Tolerance of fondaparinux in a patient allergic to heparins and other glycosaminoglycans. Contact Dermatitis 2003; 49: 158-9.
- 6 Maetzke J, Hinrichs R, Staib G. et al. Fondaparinux as a novel therapeutic alternative in a patient with heparin allergy. Allergy 2004; 59: 237-8.
- 7 Koch P. Delayed-type hypersensitivity skin reactions due to heparins and heparinoids. Tolerance of recombinant hirudins and of the new synthetic anticoagulant fondaparinux. Contact Dermatitis 2003; 49: 276-80.
- 8 Jappe U, Juschka U, Kuner N. et al. Fondaparinux: a suitable alternative in cases of delayed-type allergy to heparins and semisynthetic heparinoids? A study of 7 cases. Contact Dermatitis 2004; 51: 67-72.
- 9 Borch JE, Bindslev-Jensen C. Delayed-type hypersensitivity to heparins. Allergy 2004; 59: 118-9.
- 10 Hirsch K, Ludwig RJ, Lindhoff-Last E. et al. Intolerance of fondaparinux in a patient allergic to heparins. Contact Dermatitis 2004; 50: 383-4.
- 11 Hohenstein E, Tsakiris D, Bircher AJ. Delayed-type hypersensitivity to the ultra-low-molecular-weight heparin fondaparinux. Contact Dermatitis 2004; 51: 149-51.
- 12 Maetzke J, Hinrichs R, Schneider LA. et al. Unexpected delayed-type hypersensitivity skin reactions to the ultra-low-molecular-weight heparin fondaparinux. Allergy 2005; 60: 413-5.
- 13 Badger NO, Butler K, Hallman LC. Excessive anticoagulation and anaphylactic reaction after rechallenge with lepirudin in a patient with heparin-induced thrombocytopenia. Pharmacotherapy 2004; 24: 1800-3.
- 14 Grassegger A, Fritsch P, Reider N. Delayed-type hypersensitity and cross-reavtivity to heparins and danaparoid: a prospective study. Dermatol Surg 2001; 27: 4752.
- 15 Gaigl Z, Pfeuffer P, Raith P. et al. Tolerance to intravenous heparin in patients with delayed-type hypersensitivity to heparins: a prospective study. Br J Haematol 2005; 128: 389-92.